DK1151007T3 - Fremgangsmåde til fremstilling af et præparat baseret på fibrinogen og fibronectin samt proteinsammensætninger fremstillet derved - Google Patents

Fremgangsmåde til fremstilling af et præparat baseret på fibrinogen og fibronectin samt proteinsammensætninger fremstillet derved

Info

Publication number
DK1151007T3
DK1151007T3 DK00906319T DK00906319T DK1151007T3 DK 1151007 T3 DK1151007 T3 DK 1151007T3 DK 00906319 T DK00906319 T DK 00906319T DK 00906319 T DK00906319 T DK 00906319T DK 1151007 T3 DK1151007 T3 DK 1151007T3
Authority
DK
Denmark
Prior art keywords
fibronectin
fibrinogen
preparation
protein compositions
well
Prior art date
Application number
DK00906319T
Other languages
Danish (da)
English (en)
Inventor
Thomas Seelich
Ralf Broermann
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK1151007T3 publication Critical patent/DK1151007T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK00906319T 1999-02-12 2000-02-10 Fremgangsmåde til fremstilling af et præparat baseret på fibrinogen og fibronectin samt proteinsammensætninger fremstillet derved DK1151007T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT20699 1999-02-12
US09/502,029 US6579537B2 (en) 1999-02-12 2000-02-10 Method for producing fibronectin and fibrinogen compositions using a polyalkylene glycol and glycine or β-alanine

Publications (1)

Publication Number Publication Date
DK1151007T3 true DK1151007T3 (da) 2006-09-04

Family

ID=25591856

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00906319T DK1151007T3 (da) 1999-02-12 2000-02-10 Fremgangsmåde til fremstilling af et præparat baseret på fibrinogen og fibronectin samt proteinsammensætninger fremstillet derved

Country Status (12)

Country Link
US (2) US6579537B2 (de)
EP (1) EP1151007B1 (de)
JP (1) JP2007131638A (de)
AT (1) ATE325133T1 (de)
AU (2) AU774118B2 (de)
CA (1) CA2362513C (de)
DE (1) DE60027695T2 (de)
DK (1) DK1151007T3 (de)
ES (1) ES2263451T3 (de)
PT (1) PT1151007E (de)
SI (1) SI1151007T1 (de)
WO (1) WO2000047621A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4771594B2 (ja) * 1999-02-12 2011-09-14 バクスター アクチェンゲゼルシャフト フィブリノーゲンおよびフィブロネクチンをベースとする製剤を生成するための方法ならびにこの方法により入手可能なタンパク質組成物
US8428685B2 (en) * 2001-09-05 2013-04-23 Given Imaging Ltd. System and method for magnetically maneuvering an in vivo device
US20050221035A1 (en) * 2004-04-01 2005-10-06 Derek Wyatt Method for reducing freeze-thaw voids in uncured adhesives
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US20070238167A1 (en) * 2006-04-04 2007-10-11 3M Innovative Properties Company Flat microfibers as matrices for cell growth
US20070231362A1 (en) * 2006-04-04 2007-10-04 3M Innovative Properties Company Schistose microfibrillated article for cell growth
CA2675157A1 (en) * 2007-01-18 2008-07-24 Baxter International Inc. Fibrin gel for controlled release of tgf-beta and uses thereof
US8377864B2 (en) 2007-06-19 2013-02-19 Baxter International Inc. Fibrin gel for controlled release of PDGF and uses thereof
EP2034010A1 (de) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Zusammensetzungen zur Reparatur und/oder Behandlung von verletztem Rückenmarksgewebe
US20100028311A1 (en) * 2008-07-09 2010-02-04 Baxter International Inc. Using of scaffold comprising fibrin for delivery of stem cells
ES2818373T3 (es) * 2009-05-28 2021-04-12 Addbio Ab Películas de proteína de múltiples capas, métodos de preparación y dispositivos de suministro de fármacos e implantes biomédicos que emplean las películas
AU2011203927A1 (en) 2010-01-08 2012-07-26 Baxter Healthcare S.A. Biomatrices to attract and retain regenerative and reparative cells
IL207586A0 (en) 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
US9371355B2 (en) * 2010-09-20 2016-06-21 Octapharma Ag Process for production of fibrinogen
KR101127127B1 (ko) * 2011-10-27 2012-03-21 주식회사 녹십자 고농도 피브리노겐 용액의 제조 방법 및 이를 이용한 피브린 실란트 제품의 제조방법
US20130202675A1 (en) 2012-02-03 2013-08-08 Dynasil Biomedical Corporation Systems and methods for the fabrication of tissue patches
CN104321340B (zh) 2012-03-13 2018-11-09 欧克塔医药公司 用于生产纤维蛋白原的改进工艺及其生产的纤维蛋白原
US11071805B2 (en) 2013-04-22 2021-07-27 Sealantium Medical Ltd. Fibrinogen-based tissue adhesive patches
CA2994959A1 (en) 2015-08-07 2017-02-16 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
US11471556B2 (en) 2015-10-19 2022-10-18 Sealantium Medical Ltd. Fibrinogen-based tissue adhesive patch
EP3365038B1 (de) 2015-10-19 2019-07-03 Sealantium Medical Ltd Verbessertes gewebeheftpflaster auf der basis von fibrinogen
CN105617451A (zh) * 2016-02-29 2016-06-01 苏州市贝克生物科技有限公司 壳聚糖基止血材料及其制备方法
CN105770970A (zh) * 2016-02-29 2016-07-20 苏州市贝克生物科技有限公司 复合多糖止血薄膜及其制备方法
IL247821A0 (en) * 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Adhesive preparations and their use
CN108017710B (zh) * 2018-01-19 2020-02-04 贵州泰邦生物制品有限公司 一种人纤维蛋白原的制备方法
EP4017511A4 (de) * 2019-08-22 2023-07-12 Awidi, Abdalla S. Verfahren zum herstellen eines d-fibrinierten blutplättchenlysats und verwendungen dieses verfahrens
KR20240044450A (ko) 2021-08-13 2024-04-04 바이오테스트 아게 피브리노겐 조성물 및 제조 방법
CN118434458A (zh) 2021-12-21 2024-08-02 奥姆里克斯生物药品有限公司 包含纤维蛋白原的制剂及其用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
DE3203775A1 (de) 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
AT389815B (de) 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
JPH0199565A (ja) * 1987-10-12 1989-04-18 Green Cross Corp:The フィブリン糊調製用キット
AT397203B (de) 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
FR2639958B1 (fr) 1988-12-06 1992-08-21 Lille Transfusion Sanguine Support biologique pour cultures cellulaires constitue de proteines plasmatiques coagulees par la thrombine, son utilisation pour la culture des keratinocytes, leur recuperation et leur transport a des fins d'utilisation therapeutique
US5196185A (en) * 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
WO1992013495A1 (en) 1991-02-07 1992-08-20 Fibratek, Inc. Fibrinogen based adhesive
JPH04347162A (ja) * 1991-05-23 1992-12-02 Japan Synthetic Rubber Co Ltd 生体組織接着剤
AT402891B (de) 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
US5288853A (en) * 1992-04-30 1994-02-22 Alpha Therapeutic Corporation Factor viii purification process
JP3133338B2 (ja) 1992-12-16 2001-02-05 イムノ・アクチエンゲゼルシャフト ウイルス的に安全な生物学的組成物の調製方法
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"
US5330974A (en) 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
AT402788B (de) 1993-08-03 1997-08-25 Immuno Ag Virussichere blutgerinnungsfaktor xiii-präparation
HRP940645A2 (en) 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
AT406019B (de) 1995-05-08 2000-01-25 Immuno Ag Verfahren zur herstellung eines arzneimittels enthaltend ein oder mehrere plasmaderivate
DE19617369A1 (de) 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
AT407117B (de) 1997-09-19 2000-12-27 Immuno Ag Fibrinschwamm
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
JP4771594B2 (ja) * 1999-02-12 2011-09-14 バクスター アクチェンゲゼルシャフト フィブリノーゲンおよびフィブロネクチンをベースとする製剤を生成するための方法ならびにこの方法により入手可能なタンパク質組成物

Also Published As

Publication number Publication date
US7241603B2 (en) 2007-07-10
AU774118B2 (en) 2004-06-17
AU2004201982A1 (en) 2004-06-03
US20030077270A1 (en) 2003-04-24
EP1151007A1 (de) 2001-11-07
WO2000047621A1 (en) 2000-08-17
AU2004201982B2 (en) 2007-12-06
PT1151007E (pt) 2006-07-31
DE60027695D1 (de) 2006-06-08
ES2263451T3 (es) 2006-12-16
JP2007131638A (ja) 2007-05-31
US20020172718A1 (en) 2002-11-21
SI1151007T1 (sl) 2006-10-31
EP1151007B1 (de) 2006-05-03
US6579537B2 (en) 2003-06-17
CA2362513A1 (en) 2000-08-17
CA2362513C (en) 2011-04-26
ATE325133T1 (de) 2006-06-15
AU2804100A (en) 2000-08-29
DE60027695T2 (de) 2007-04-26

Similar Documents

Publication Publication Date Title
DK1151007T3 (da) Fremgangsmåde til fremstilling af et præparat baseret på fibrinogen og fibronectin samt proteinsammensætninger fremstillet derved
DE60228961D1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des mop-b
ATE489365T1 (de) Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon
NO20073846L (no) Ladet termoplastisk resin-basert bitumlinos mastik
ATE501113T1 (de) Verfahren zur herstellung von 2-halogenacyl-3- amino-acrylsäure- derivaten
ATE426021T1 (de) Verfahren zur herstellung von biopterinen
DE69433010D1 (de) Verfahren zur darstellung von oligonukleotiden
ATE526401T1 (de) Verfahren zur herstellung von proteinen mit freien cysteinresten
ATE389678T1 (de) Verfahren zur herstellung von wässrigen dispersionen
WO2002051449A3 (en) Composition and process for bone growth and repair
DE60030988D1 (de) Verfahren zur Herstellung Von L-Aminosäuren durch Erhöhung des zellulären NADPH
DE60119711D1 (de) Verfahren zur herstellung von funktionalierten polyalkyleniminen, diese enthaltende zusammenstellungen und ihre verwendungen
ATE293632T1 (de) Verfahren zur herstellung von alkylverbrückten ligandsystemen und übergangsmetallverbindungen
BRPI0416672A (pt) método de produção de uma composição granular contendo lecitina e composição granular contendo lecitina
ATE537173T1 (de) Verfahren zur herstellung von cucurbiturilen
ATE335750T1 (de) Verfahren zur herstellung von organosilylalkylpolysulfanen
ATE359287T1 (de) Ein verfahren zur herstellung von clopidogrel
DE60038281D1 (de) Verfahren zur herstellung von optisch aktiven pyridinethanol-derivaten
ATE386734T1 (de) Verfahren zur herstellung von (4-hydroxy-6-oxo- tetrahydropyran-2-yl) acetonitril und dessen derivaten
TW200502252A (en) Formulations of modified antibodies and methods of making the same
DE59709792D1 (de) Ringannelierte dihydropyrane, verfahren zur herstellung sowie deren verwendung
DE60336328D1 (de) Verfahren zur produktion von pflanzen mit verbesserter transpirationseffizienz sowie davon produzierte pflanzen
ATE546432T1 (de) Verfahren zur herstellung von 2- aminomethylpyridin-derivate
ATE325829T1 (de) Verfahren zur herstellung von polyasparaginsäure
ATE271053T1 (de) Verfahren zur herstellung von beta-hydroxyestern